IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,624 | +102.0% | 35,812 | +82.7% | 0.00% | 0.0% |
| Q2 2023 | $804 | +14.7% | 19,604 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $701 | -5.3% | 19,604 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $740 | -99.9% | 19,604 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $867,000 | +19.4% | 19,604 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $726,000 | 0.0% | 19,604 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $726,000 | +21.6% | 19,604 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $597,000 | -9.3% | 19,604 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $658,000 | -15.9% | 19,604 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $782,000 | -11.2% | 19,604 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $881,000 | -20.5% | 19,604 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $1,108,000 | +19.1% | 19,604 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $930,000 | -19.6% | 19,604 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $1,156,000 | +24.7% | 19,604 | 0.0% | 0.01% | +16.7% |
| Q1 2020 | $927,000 | -21.6% | 19,604 | +0.2% | 0.01% | -14.3% |
| Q4 2019 | $1,182,000 | +0.9% | 19,566 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $1,172,000 | -6.8% | 19,566 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $1,258,000 | -20.8% | 19,566 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $1,588,000 | +21.8% | 19,566 | -18.9% | 0.01% | +11.1% |
| Q4 2018 | $1,304,000 | +4.6% | 24,121 | -0.2% | 0.01% | +12.5% |
| Q3 2018 | $1,247,000 | +23.7% | 24,173 | -0.1% | 0.01% | +14.3% |
| Q2 2018 | $1,008,000 | -5.7% | 24,197 | -0.2% | 0.01% | 0.0% |
| Q1 2018 | $1,069,000 | -15.6% | 24,244 | -3.7% | 0.01% | -12.5% |
| Q4 2017 | $1,266,000 | +2.3% | 25,177 | +3.2% | 0.01% | -11.1% |
| Q3 2017 | $1,237,000 | -0.3% | 24,391 | +0.0% | 0.01% | 0.0% |
| Q2 2017 | $1,241,000 | +26.9% | 24,390 | +0.3% | 0.01% | +28.6% |
| Q1 2017 | $978,000 | -19.0% | 24,325 | -3.6% | 0.01% | -30.0% |
| Q4 2016 | $1,207,000 | +25.2% | 25,228 | -4.1% | 0.01% | +25.0% |
| Q3 2016 | $964,000 | +48.8% | 26,316 | -5.4% | 0.01% | +60.0% |
| Q2 2016 | $648,000 | -42.5% | 27,817 | +0.1% | 0.01% | -44.4% |
| Q1 2016 | $1,126,000 | -37.4% | 27,794 | -4.4% | 0.01% | -40.0% |
| Q4 2015 | $1,800,000 | – | 29,062 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |